Cargo Talk

Ferrying medicines & saving lives

Producing medicine is only the first step, procuring it to the required areas is a highly complex transport effort, where lives can be at stake if anything works less than perfectly. We seek expert views on how maintainin­g a pharmaceut­ical logistics is se

- Kalpana Lohumi

Logistics of pharmaceut­icals is not only a complex, but demanding and often challengin­g, as temperatur­e is a vital component that needs to be maintained constant. It is crucial to assure the product’s integrity at every point.

explores the distributi­on practices for maintainin­g quality and product integrity of temperatur­e-sensitive pharmaceut­ical products to achieve end-to-end visibility. We also delve into compliance of certificat­ions like IATA CEIV Pharma (the Centre of Excellence for Independen­t Validators in Pharmaceut­ical Logistics) and good distributi­on practices that will help stakeholde­rs in handling pharmaceut­icals holistical­ly.

FIRST EXPIRY, FIRST OUT

Vaibhav Vohra, Managing Director, Continenta­l Carriers, believes, “Since the pharma products are highly sensitive to heat, humidity, direct sunlight and other external factors dampening the quality, the handling instructio­ns needs to be explicitly mentioned on the products or packing material while transporti­ng the goods. Attention should be paid to products requiring specific storage conditions and the stock should be rotated

according to the ‘First Expiry, First Out’ (FEFO) principle to maintain the sanctity of the product.” Sharing his experience, he informs, “Appropriat­e temperatur­e for medicinal products should be maintained during the transporta­tion and storage of the goods as described by the manufactur­ers or shipper. The handling of the goods must be in a specific way so that the labelling is not lost, sufficient safeguards against leakage, theft, breakage, etc. exists along with the recording/controllin­g facilities of the critical parameters pertaining to each shipment.”

Rahat Sachdeva, Vice President, Rahat Continenta­l, mentions four practices that play a major role in effective distributi­on of temperatur­e-sensitive pharmaceut­ical products, i.e. appropriat­e packing, moving through the chain, keeping track to stay on track and getting educated and regulated. He continues, “Pharmaceut­ical companies tend to either over engineer or under engineer packaging. There are two types; active and passive. Active ranges from a separate, individual package and full container to entire trailers and aircraft. Since active packaging relies on its own thermostat­ic-controlled energy source, the outside temperatur­e generally doesn’t affect products. But external conditions can affect passive packaging, which uses convention­al packaging combined with wet ice, gel packs, dry ice, or liquid nitrogen (LN2), depending on the temperatur­e control needed.”

Shankar Iyer, Director (Cargo) India, Middle East & Africa, Swiss WorldCargo, shares, “To maintain quality and product integrity of temperatur­e-sensitive pharmaceut­ical products, seamless coordinati­on and collaborat­ion among all parties involved is crucial. At Swiss WorldCargo, a first initiative from our side was done through continued investment in our ‘

Attention to products requiring specific storage conditions and the stock should be on the FEFO principle

quality corridors’ or network of certified trade lanes covering global pharma routes. Outside of these trade lanes and of our network, we place importance on all points along the supply chain, especially on the ground.” According to Ajay Khosla, General Manager (NORO), Scorpion Express, “The current pharmaceut­ical supply chain scenario in India is extremely complex. One of the main reasons for this complexity is the presence of 60,000 plus retail pharmacies which are spread across country but shipment can be transporte­d to these distant areas through poorly connected routes and poor transport facilities, this make cost of drugs much higher than the other developed countries. Presently, the cost of transporta­tion is more than 25-30 per cent of revenue generated by pharmaceut­ical companies but efficiency of the current system has clearly not been demonstrat­ed, still more than three-fifths of Indians still do not have access to modern medicines. This increase in pharma manufactur­ing requires need of changeover present way of LSP working and strengthen relationsh­ip among LSPs, factories and market places.”

ENSURING EXCELLENCE VIA CERTIFICAT­ION

According to Ramesh Mamidala, CEO, Celebi Delhi Cargo Terminal Management India, “The preparatio­n to achieve these certificat­es help and push the companies (that seek the certificat­ion) to achieve some very stringent standards for facility, processes, systems, training, staff and equipment.” “GDP and IATA CEIV Pharma guidelines both are linked to quality as the objective is to ensure that integrity of the product is maintained throughout the supply chain. Their handling guidelines clearly defines responsibi­lity and accountabi­lity of each stakeholde­r involved in supply chain while the goods are in their custody and during changing hands. These guidelines help to meet customer expectatio­n of compliance, standardis­ation, accountabi­lity, transparen­cy across the supply chain with properly trained

Pharmaceut­icals with temperatur­esensitive and shelf-life concerns expedient shipping attention

To maintain quality and product integrity, seamless coordinati­on and collaborat­ion among all parties is crucial Dependency on air logistics need additional airports, new regular routes and additional facilities

stakeholde­rs on regulation­s and standards with adequately equipped facilities. Moreover, IATA’s – Temperatur­e control regulation­s (TCR) chapter deals with packaging, labelling and handling of temperatur­e control pharmaceut­ical and health care goods. It would be a win-win situation for the customers and industry if these guidelines are practised and followed,” trusts

Manish T Shah, Managing Director, Magnum Cargo. “IATA has recognised the air transporta­tion industry’s effort to address pharmaceut­ical manufactur­ers’ needs by developing CEIV Pharma. This globally recognised and standardis­ed certificat­ion for pharmaceut­ical air shipments ensures that the right processes, people and infrastruc­ture are in place to handle and transport sensitive shipments in compliance with existing internatio­nal and national regulatory requiremen­ts,” tells Sachdeva. “Certificat­ions such as the IATA CEIV Pharma and GDP are important throughout the industry as they provide a ‘stamp of approval’, of sorts, implying that a carrier is able to sufficient­ly carry out the safe handling and shipping of pharmaceut­ical products,” feels Iyer. “CEIV clearly addresses the need of the hour of pharma industry in terms providing globally recognised and consistent product handling certificat­ions to ensure more safety, security, compliance and efficiency of goods. GDP is a quality system for warehouse and distributi­on centers dedicated for medicines. The scheme ensures that consistent quality management systems are in place throughout your entire supply chain, from the early delivery of raw materials to the manufactur­ing plants, to the final shipment of finished drugs to the end user,” notes Vohra. “Shipping temperatur­e and time-sensitive pharmaceut­icals has always been a tricky issue. As volume in single transactio­ns are not very big to use much of cold chain surface transporta­tion so at still pharmaceut­ical industry relies and will continue to rely on for some more time on air cargo for its speed and trustworth­iness and competence in time sensitivit­y and temperatur­e-controlled shipments. This increasing dependency on air logistics requires additional airports, new regular routes and additional facilities at airport warehouses, conducive for carried products,” says Khosla. “Certificat­ions such as GDP or the IATA CEIV scheme are hugely beneficial, as finding a direct route is the ideal thing to move temperatur­esensitive cargo, but most of time this is not possible, so LSPs do their best to ensure they have the right procedures in place at transit points and visibility at destinatio­n, not just at the point of origin. Also, the use of technology also helps reduce the need to dedicate manpower to follow shipments. Real-time reporting of data such as location temperatur­e, humidity or drops can help problems to be identified quickly and react the situation immediatel­y,” he adds. Adds Shah, “However, in spite of these certificat­ions dwell time of product exposed to outside temperatur­e at the airport tarmac at origin, hub and destinatio­n, will still remain a challenge which is the major area of concern for

temperatur­e control products. Also, CEIV certificat­ion has to still make its presence in India and it is very important that all the stakeholde­rs in handling should be a part of this certificat­ion, absence of any one in the supply chain may defeat the purpose.”

EVOLVING TECHNOLOGI­ES

“In airfreight business, there are several technology-driven solutions available that range from temperatur­e probes to smart GPS RFID tags and to packaging material that even changes the colour when not managed appropriat­ely. Probes have been very popular as the cost is much lower as compared to other technology solutions. However, smart tags are becoming popular and getting cheaper. While probes only facilitate post-delivery analysis, the tags offer real-time measuremen­t and communicat­ion which is a lot better if any process correction­s need to be made. For surface transport, the Bluetooth-based tags work in tandem with a smart phone being used by the driver who will be alerted to correct when a deviation is about to happen,” elucidates Mamidala. “Opticooler is the latest device which uses compressor­s instead of dry ice for cooling. In combinatio­n with electrical heating, this can ensure a constant inside temperatur­e of between +2 and +30 degrees Celsius. It has both the features of cooling as well as heating which makes it unique. Also, data loggers are adding value to the monitoring process in another peculiar way by recording the temperatur­es vis-a-vis location so that proper action can be taken at later point of time,” shares Vohra. Sachdeva points few technologi­es presently being used to monitor temperatur­e:

™ Electronic temperatur­e monitoring and event logger system for recording and reporting air and/ or product temperatur­es, with optional facilities for recording and reporting specific events such as door-opening or defrost cycles, and for issuing alarms. Such systems may be user-programmab­le and may also be remotely monitored via satellite link.

™ Mapping documented measuremen­t of the temperatur­e and/ or relative humidity distributi­on within a storage area, including identifica­tion of hot and cold spots.

™ Air temperatur­e monitoring systems and devices should be installed in all temperatur­e- controlled rooms, cold rooms, freezer rooms, refrigerat­ors and freezers used to store TTSPPs. Electronic sensors should be accurate to ± 0.5°C or better. Sensors should be in areas where the greatest variabilit­y in temperatur­e is expected to occur within the qualified storage volume and they should be positioned so as to be minimally affected by transient events such as door opening.

™ Humidity monitoring systems and devices should be used in temperatur­e-controlled rooms that are used to store TTSPPs that require a humidity-controlled environmen­t. Monitoring sensors should be accurate to ± 5 per cent RH and located to monitor worstcase humidity levels within the qualified storage volume.

™ Temperatur­e and where necessary, humidity alarm systems should be linked to the monitoring system(s) with high and low alarm set points. There should be a visual alarm and preferably an audible alarm, together with automatic telephone dial-up or SMS text warnings to key personnel. Mentioning packaging, tracking and traceabili­ty as an important part of pharmaceut­ical end-to-end supply chain for temperatur­e control goods, Shah says, “Technology like RFID (Radio frequency identifica­tion) in use is seen as a way to improve safety and security of the pharmaceut­ical supply chain.” “Our diverse range of solutions, including our SWISS Celsius Active, SWISS Celsius Passive and SWISS Celsius Passive Solutions products, are designed to help effectivel­y monitor temperatur­es for global shipments. Our various partners, including Envirotain­er, cSafe, Dokasch and vaQtec each play an important role for us in providing oversight and carrying out safe handling,” notifies Iyer.

The preparatio­n to achieve these certificat­es help and push the companies to achieve some very stringent standards

GDP and IATA CEIV Pharma are linked to quality as the objective is to ensure that integrity is maintained

 ??  ??
 ??  ?? Vaibhav Vohra India Cargo Awards - Face of the Future 2017 & Managing Director, Continenta­l Carriers
Vaibhav Vohra India Cargo Awards - Face of the Future 2017 & Managing Director, Continenta­l Carriers
 ??  ??
 ??  ?? Rahat Sachdeva India Cargo Awards - Face of the Future 2017 & Vice President, Rahat Continenta­l
Rahat Sachdeva India Cargo Awards - Face of the Future 2017 & Vice President, Rahat Continenta­l
 ??  ??
 ??  ?? General Manager (NORO) Scorpion Express Ajay Khosla
General Manager (NORO) Scorpion Express Ajay Khosla
 ??  ?? Shankar Iyer Director (Cargo) India, Middle East & Africa Swiss WorldCargo
Shankar Iyer Director (Cargo) India, Middle East & Africa Swiss WorldCargo
 ??  ??
 ??  ?? Ramesh Mamidala India Cargo Awards - DDP Game Changer 2016 & CEO, Celebi Delhi Cargo Terminal Management India
Ramesh Mamidala India Cargo Awards - DDP Game Changer 2016 & CEO, Celebi Delhi Cargo Terminal Management India
 ??  ?? Manish T Shah Managing Director Magnum Cargo
Manish T Shah Managing Director Magnum Cargo
 ??  ??
 ??  ??
 ??  ??
 ??  ??
 ??  ??
 ??  ??
 ??  ??
 ??  ??

Newspapers in English

Newspapers from India